209 related articles for article (PubMed ID: 25940959)
1. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
Ortalda C; Noli C; Colombo S; Borio S
Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
[TBL] [Abstract][Full Text] [Related]
2. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
4. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oclacitinib for the control of feline atopic skin syndrome: correlating plasma concentrations with clinical response.
Carrasco I; Ferrer L; Puigdemont A
J Feline Med Surg; 2022 Aug; 24(8):787-793. PubMed ID: 34612749
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
[TBL] [Abstract][Full Text] [Related]
7. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Walsh KF; Follis SI; King VI; Tena JK; Stegemann MR
Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
[TBL] [Abstract][Full Text] [Related]
8. Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study.
Maina E; Fontaine J
J Feline Med Surg; 2019 Oct; 21(10):967-972. PubMed ID: 30427273
[TBL] [Abstract][Full Text] [Related]
9. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study.
Simpson AC; Schissler JR; Rosychuk RAW; Moore AR
Vet Dermatol; 2017 Oct; 28(5):485-e113. PubMed ID: 28513001
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
Marsella R; Ahrens K
Vet Dermatol; 2018 Oct; 29(5):439-e146. PubMed ID: 29926994
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis.
Steffan J; Olivry T; Forster SL; Seewald W
Vet Dermatol; 2012 Oct; 23(5):410-e77. PubMed ID: 22823903
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study.
Schmidt V; Buckley LM; McEwan NA; Rème CA; Nuttall TJ
Vet Dermatol; 2012 Feb; 23(1):11-6, e3-4. PubMed ID: 21718369
[TBL] [Abstract][Full Text] [Related]
13. Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
Noli C; Cena T
Vet Dermatol; 2015 Dec; 26(6):481-3, e112-3. PubMed ID: 26345275
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial.
Koch SN; Torres SMF; Diaz S; Gilbert S; Rendahl A
Vet Dermatol; 2018 Apr; 29(2):107-e43. PubMed ID: 29068099
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
Wildermuth K; Zabel S; Rosychuk RA
Vet Dermatol; 2013 Dec; 24(6):576-81, e137-8. PubMed ID: 24112588
[TBL] [Abstract][Full Text] [Related]
16. Prospective open pilot study on the use of ciclosporin for feline allergic skin disease.
Noli C; Scarampella F
J Small Anim Pract; 2006 Aug; 47(8):434-8. PubMed ID: 16911110
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
Wisselink MA; Willemse T
Vet J; 2009 Apr; 180(1):55-9. PubMed ID: 18294881
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity-associated dermatoses.
Hobi S; Linek M; Marignac G; Olivry T; Beco L; Nett C; Fontaine J; Roosje P; Bergvall K; Belova S; Koebrich S; Pin D; Kovalik M; Meury S; Wilhelm S; Favrot C
Vet Dermatol; 2011 Oct; 22(5):406-13. PubMed ID: 21410570
[TBL] [Abstract][Full Text] [Related]
19. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
20. Establishment of diagnostic criteria for feline nonflea-induced hypersensitivity dermatitis.
Favrot C; Steffan J; Seewald W; Hobi S; Linek M; Marignac G; Olivry T; Beco L; Nett C; Fontaine J; Roosje P; Bergvall K; Belova S; Koebrich S; Pin D; Kovalik M; Meury S; Wilhelm S
Vet Dermatol; 2012 Feb; 23(1):45-50, e11. PubMed ID: 21899606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
